Literature DB >> 33216038

Association Between APOE Alleles and Change of Neuropsychological Tests in the Long Life Family Study.

Mengtian Du1, Stacy L Andersen2, Nicole Schupf3,4, Mary F Feitosa5, Megan S Barker3, Thomas T Perls2, Paola Sebastiani6.   

Abstract

BACKGROUND: The Long Life Family Study (LLFS) is a family based, prospective study of healthy aging and familial longevity. The study includes two assessments of cognitive function that were administered approximately 8 years apart.
OBJECTIVE: To test whether APOE genotype is associated with change of cognitive function in older adults.
METHODS: We used Bayesian hierarchical models to test the association between APOE alleles and change of cognitive function. Six longitudinally collected neuropsychological test scores were modelled as a function of age at enrollment, follow-up time, gender, education, field center, birth cohort indicator (≤1935, or >1935), and the number of copies of ɛ2 or ɛ4 alleles.
RESULTS: Out of 4,587 eligible participants, 2,064 were male (45.0%), and age at enrollment ranged from 25 to 110 years, with mean of 70.85 years (SD: 15.75). We detected a significant cross-sectional effect of the APOEɛ4 allele on Logical Memory. Participants carrying at least one copy of the ɛ4 allele had lower scores in both immediate (-0.31 points, 95% CI: -0.57, -0.05) and delayed (-0.37 points, 95% CI: -0.64, -0.10) recall comparing to non-ɛ4 allele carriers. We did not detect any significant longitudinal effect of the ɛ4 allele. There was no cross-sectional or longitudinal effect of the ɛ2 allele.
CONCLUSION: The APOEɛ4 allele was identified as a risk factor for poorer episodic memory in older adults, while the APOEɛ2 allele was not significantly associated with any of the cognitive test scores.

Entities:  

Keywords:  APOE; cognition; longevity; longitudinal studies

Year:  2021        PMID: 33216038      PMCID: PMC7952213          DOI: 10.3233/JAD-201113

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  28 in total

Review 1.  ApoE genotype accounts for the vast majority of AD risk and AD pathology.

Authors:  Jacob Raber; Yadong Huang; J Wesson Ashford
Journal:  Neurobiol Aging       Date:  2004 May-Jun       Impact factor: 4.673

2.  APOE genotype and cognitive decline in a middle-aged cohort.

Authors:  C K Blair; A R Folsom; D S Knopman; M S Bray; T H Mosley; E Boerwinkle
Journal:  Neurology       Date:  2005-01-25       Impact factor: 9.910

Review 3.  APOE Alleles and Extreme Human Longevity.

Authors:  Paola Sebastiani; Anastasia Gurinovich; Marianne Nygaard; Takashi Sasaki; Benjamin Sweigart; Harold Bae; Stacy L Andersen; Francesco Villa; Gil Atzmon; Kaare Christensen; Yasumichi Arai; Nir Barzilai; Annibale Puca; Lene Christiansen; Nobuyoshi Hirose; Thomas T Perls
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-01-01       Impact factor: 6.053

4.  The apolipoprotein E epsilon 2 allele and decline in episodic memory.

Authors:  R S Wilson; J L Bienias; E Berry-Kravis; D A Evans; D A Bennett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

5.  Trade-offs in the effects of the apolipoprotein E polymorphism on risks of diseases of the heart, cancer, and neurodegenerative disorders: insights on mechanisms from the Long Life Family Study.

Authors:  Alexander M Kulminski; Konstantin G Arbeev; Irina Culminskaya; Svetlana V Ukraintseva; Eric Stallard; Michael A Province; Anatoli I Yashin
Journal:  Rejuvenation Res       Date:  2015-04       Impact factor: 4.663

6.  Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.

Authors:  Richard J Caselli; Amylou C Dueck; David Osborne; Marwan N Sabbagh; Donald J Connor; Geoffrey L Ahern; Leslie C Baxter; Steven Z Rapcsak; Jiong Shi; Bryan K Woodruff; Dona E C Locke; Charlene Hoffman Snyder; Gene E Alexander; Rosa Rademakers; Eric M Reiman
Journal:  N Engl J Med       Date:  2009-07-16       Impact factor: 91.245

7.  Apolipoprotein E and cognitive change in an elderly population.

Authors:  B T Hyman; T Gomez-Isla; M Briggs; H Chung; S Nichols; F Kohout; R Wallace
Journal:  Ann Neurol       Date:  1996-07       Impact factor: 10.422

8.  Protective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: A three-year longitudinal study.

Authors:  Yeo Jin Kim; Sang Won Seo; Seong Beom Park; Jin Ju Yang; Jin San Lee; Juyoun Lee; Young Kyoung Jang; Sung Tae Kim; Kyung-Han Lee; Jong Min Lee; Jae-Hong Lee; Jae Seung Kim; Duk L Na; Hee Jin Kim
Journal:  Sci Rep       Date:  2017-05-15       Impact factor: 4.379

Review 9.  Putative Survival Advantages in Young Apolipoprotein ɛ4 Carriers are Associated with Increased Neural Stress.

Authors:  Carr J Smith; J Wesson Ashford; Thomas A Perfetti
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 10.  The Contribution of Genetic Factors to Cognitive Impairment and Dementia: Apolipoprotein E Gene, Gene Interactions, and Polygenic Risk.

Authors:  Jialing Fan; Wuhai Tao; Xin Li; He Li; Junying Zhang; Dongfeng Wei; Yaojing Chen; Zhanjun Zhang
Journal:  Int J Mol Sci       Date:  2019-03-07       Impact factor: 5.923

View more
  1 in total

1.  Studying the Interplay Between Apolipoprotein E and Education on Cognitive Decline in Centenarians Using Bayesian Beta Regression.

Authors:  Qingyan Xiang; Stacy Lynn Andersen; Thomas T Perls; Paola Sebastiani
Journal:  Front Genet       Date:  2021-01-08       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.